Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain

JAMA Internal Medicine

Volumn 175, Issue 2, 2015, Pages 186-193

  Fournier, Jean Pascal ^a   Azoulay, Laurent ^d   Yin, Hui ^b   Montastruc, Jean Louis ^a,c   Suissa, Samy ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; TRAMADOL; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; RISK; TREATMENT DURATION; UNITED KINGDOM; AGED; CHEMICALLY INDUCED; COMPARATIVE STUDY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CASE-CONTROL STUDIES; CODEINE; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; PAIN; TRAMADOL;

EID: 84922263891     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.6512     Document Type: Article

References (32)

1. The National Prescribing Centre. Pain Overview-Data Focused Commentaries. http://www.npc.nhs.uk/therapeutics/pain/overview/data.php. Updated April 2010. Accessed September 22, 2014
2. Manchikanti L, Helm S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012; 15(3)(suppl):S9-S38
3. Grandvuillemin A, Jolimoy G, Authier F, Dautriche A, Duhoux F, Sgro C. Tramadol-induced hypoglycemia: 2 cases [in French]. Presse Med. 2006;35(12, pt 1):1842-1844
4. Tavassoli N, Lapeyre-Mestre M, Sommet A, Montastruc J-L; French Association of Regional Pharmacovigilance Centres. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol). Br J Clin Pharmacol. 2009;68(3):422-426
5. Taugourdeau S, Chiche L, Rouby F, et al. Severe hypoglycemia induced by tramadol: two new cases of an unlisted side effect [in French]. Rev Med Interne. 2011;32(11):703-705
6. Jonville-Bera A-P, Marie A, Magba D, Gedon E, Autret-Leca E. Tramadol-induced hypoglycemia in a diabetic patient [in French]. Therapie. 2010;65(5): 499-500
7. Mugunthan N, Davoren P. Danger of hypoglycemia due to acute tramadol poisoning. Endocr Pract. 2012;18(6):e151-e152
8. Bourne C, Gouraud A, Daveluy A, et al; French Association of Regional Pharmacovigilance Centres. Tramadol and hypoglycaemia: comparison with other step 2 analgesic drugs. Br J Clin Pharmacol. 2013;75(4):1063-1067
9. Bonds DE,MillerME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909
10. Zoungas S, Patel A, Chalmers J, et al; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363(15):1410-1418
11. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND,Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35(9):1897-1901
12. Cryer PE. Death during intensive glycemic therapy of diabetes: mechanisms and implications. Am J Med. 2011;124(11):993-996
13. Raffa RB, FriDerichs E, ReimannW, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharmacol Exp Ther. 1992;260 (1):275-285
14. Garca Rodrguez LA, Prez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998; 45(5):419-425
15. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4-14
16. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60(572):e128-e136
17. Suissa S. Novel approaches to pharmacoepidemiology study design and statistical analysis. In: Strom BL, ed. Pharmacoepidemiology. 4th ed. Chichester, England: John Wiley & Sons, Ltd; 2006:811-829
18. Miettinen OS, Caro JJ. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol. 1989;42(4):325-331
19. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, BrookhartMA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512-522
20. MaclureM. The case-crossover design: amethod for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144-153
21. Hebert C, Delaney JAC, Hemmelgarn B, Lvesque LE, Suissa S. Benzodiazepines and elDerly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf. 2007; 16(8):845-849
22. Suissa S. The case-time-control design. Epidemiology. 1995;6(3):248-253
23. Cepeda MS, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol. 2007;34(3):543-555
24. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013;8:CD004959
25. DonoVan MH, Tecott LH. Serotonin and the regulation of mammalian energy balance. Front Neurosci. 2013;7:36
26. Yamada J, Sugimoto Y, Kimura I, Takeuchi N, Horisaka K. Serotonin-induced hypoglycemia and increased serum insulin levels in mice. Life Sci. 1989;45(20):1931-1936
27. Chi T-C, Ho Y-J, Chen W-P, et al. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. Life Sci. 2007;80(20):1832-1838
28. Derijks HJ, Meyboom RHB, Heerdink ER, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol. 2008;64(5):531-538
29. Derijks HJ, Heerdink ER, De Koning FH, Janknegt R, Klungel OH, Egberts AC. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiol Drug Saf. 2008;17(4):336-344
30. Cheng JT, Liu IM, Chi TC, Tzeng TF, Lu FH, Chang CJ. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. 2001;50(12):2815-2821
31. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915-920
32. Khalid JM, Raluy-Callado M, Curtis BH, Boye KS, Maguire A, Reaney M. Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics. Int J Clin Pract. 2014;68(1):40-48